Insiders · DMTK

Gary E. Jacobs

Director at DermTech, Inc. (DMTK)

Gary E. Jacobs has filed 2 insider reports with the SEC since April 2021, as director at DermTech, Inc. (DMTK). The latest filing, on April 21, 2021, reports exercise or conversion of a derivative at DermTech, Inc. (DMTK).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Gary E. Jacobs is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
DermTech, Inc. logo
DMTK
DermTech, Inc.
Director547,438Apr 21, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Gary E. Jacobs with

Questions about Gary E. Jacobs

What is Gary E. Jacobs's role at DermTech, Inc.?
Gary E. Jacobs reports to the SEC as director at DermTech, Inc. (DMTK), according to the latest filing on April 21, 2021.
How many shares does Gary E. Jacobs own?
After the latest filing that states it, Gary E. Jacobs directly owned 547,438 shares of DermTech, Inc. (DMTK). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Gary E. Jacobs bought or sold stock recently?
No open-market purchases or sales by Gary E. Jacobs are on file. The filings report exercise or conversion of a derivative and grant or award.
How do I get alerts when Gary E. Jacobs files?
Follow Gary E. Jacobs on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Gary E. Jacobs (SEC CIK 0001726114). Totals count each trade once, skipping amendments whose original is on file, from Apr 12, 2021 on. View on SEC EDGAR